Evidence map›Paper›PMID 30860855›Full record

ArticleOrganic letters2019

A Mild, DNA-Compatible Nitro Reduction Using B

Huang-Chi Du, Nicholas Simmons, John C Faver, Zhifeng Yu, Murugesan Palaniappan, Kevin Riehle, Martin M Matzuk

Open access · hybridAbstract read
In one paragraph

Article in Organic letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Pyridine-boryl radical mediated synthesis of quinolinesOrganic chemistry frontiers : an international journal of organic chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. FSOACS medicinal chemistry letters · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Reductive site-selective atypicalScience advances · 2022
    Article
  14. Article
  15. Article
  16. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 MProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Review
  20. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huang-Chi DuCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Nicholas SimmonsCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.ORCID 0000-0003-0766-5382
John C FaverCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Zhifeng YuCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Murugesan PalaniappanCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Kevin RiehleCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Martin M MatzukCenter for Drug Discovery , Baylor College of Medicine , Houston , Texas 77030 , United States.
Baylor College of Medicine · US

Funding

Targeting sperm-specific proteins during meiosis and sperm morphogenesisP01HD087157 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GARCIA, THOMAS · 2017 to 2021
$6.2M
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancerP20CA221731 · NCI · UNIVERSITY OF HOUSTON · PI YUSTEIN, JASON · 2018 to 2021
$1.1M
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancerP20CA221729 · NCI · BAYLOR COLLEGE OF MEDICINE · PI YUSTEIN, JASON · 2018 to 2021
$1.0M
NCI NIH HHS P20 CA221729NCI NIH HHS P20 CA221731NICHD NIH HHS P01 HD087157
6 · The paper itself

Abstract

A hypodiboric acid system for the reduction of nitro groups on DNA-chemical conjugates has been developed. This transformation provided good to excellent yields of the reduced amine product for a variety of functionalized aromatic, heterocyclic, and aliphatic nitro compounds. DNA tolerance to reaction conditions, extension to decigram scale reductions, successful use in a DNA-encoded chemical library synthesis, and subsequent target selection are also described.

Indexed as

AminesBoron CompoundsCatalysisDNAMolecular StructureNitro CompoundsAminesBoron CompoundsDNANitro Compounds

Identifiers

PMID30860855
PMCPMC6457042
OpenAlexW2920795781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.